Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank29
5Y CAGR-35.3%
Studio
Year-over-Year Change

Price-to-book ratio

5Y CAGR
-35.3%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20251.97-97.8%
202489.93+1120.9%
2023-8.81+53.6%
2022-18.99-227.7%
202114.87-14.3%
202017.36+161.0%
20196.65+97.9%
20183.36-31.0%
20174.87+19.3%
20164.08-